MAZE vs VOR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VOR Captures Institutional Edge (3โ1 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vor Biopharma Inc. Common Stock (VOR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while MAZE counters with relative strength in Valuation. Fundamentally, MAZE trades at 8.5x Forward P/E with -820.8% operating margin (+0.0% YoY revenue) versus VOR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MAZE sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro) against VOR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MAZE | VOR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.0B | $1.2B | Larger Scale | MAZE |
| Trailing P/E Ratio Valuation | 8.5x | 0.1x | Lower Multiple | VOR |
| Forward P/E Ratio Valuation | 8.5x | N/M | Lower Multiple | MAZE |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | -820.8% | 0.0% | Higher Margin | VOR |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -37.5% | -125.4% | Higher ROE | MAZE |
| 52-Week Range Position Momentum | 38% ($22โ$54) | 65% ($6โ$26) | Stronger Trend | VOR |
| Beta / 30D Volatility Risk Regime | 0.78ฮฒ ยท 54% Vol | 1.91ฮฒ ยท 61% Vol | Lower Realized Risk | MAZE |
| Unified Institutional Score Composite Signal | 34.8 / 100 (SELL) | 57.8 / 100 (HOLD) | Higher Composite | VOR |